SAFEHEART is an open, multicenter, long-term prospective cohort study in a well-defined FH population, performed in collaboration with 25 outpatient lipid clinics in Spain covering a widespread geographical distribution.
A Coordinating Centre was created under the supervision of the Fundación Hipercolesterolemia Familiar (CC-FHF) to organise and to implement the follow-up and it is constituted by a Director, a Scientific Committee, an epidemiologist, a statistician, dietician and two administrative assistants for phone calling and data–management.
This study was approved by the ethics committees and all eligible subjects gave written informed consent to participate and to obtain blood samples for research purpose before their inclusion in the study.
Comments are closed.